Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.090
-0.100 (-4.57%)
At close: Dec 1, 2025, 4:00 PM EST
2.141
+0.051 (2.42%)
After-hours: Dec 1, 2025, 5:57 PM EST

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2016 - 2020
8455395-
Upgrade
Market Cap Growth
16.04%-10.66%-90.80%-44.08%--
Upgrade
Enterprise Value
2154683-
Upgrade
Last Close Price
2.095.9463.99738.851377.00-
Upgrade
PB Ratio
1.231.10-1.8817.427.11-
Upgrade
P/TBV Ratio
1.491.10-17.427.11-
Upgrade
Debt / Equity Ratio
---0.12--0.17
Upgrade
Quick Ratio
5.726.220.121.7912.072.16
Upgrade
Current Ratio
6.036.580.142.0312.373.24
Upgrade
Return on Equity (ROE)
-302.25%-657.17%-4408.31%-181.47%-160.92%-356.06%
Upgrade
Return on Assets (ROA)
-97.46%-107.38%-189.73%-90.97%-88.35%-130.96%
Upgrade
Return on Capital (ROIC)
-188.65%-335.63%-1651.80%-113.36%-98.09%-191.48%
Upgrade
Return on Capital Employed (ROCE)
-116.70%-113.30%383.10%-488.30%-92.30%-246.00%
Upgrade
Earnings Yield
-86.00%-103.51%-203.75%-28.04%-13.03%-
Upgrade
FCF Yield
-101.76%-157.47%-172.40%-16.82%-7.08%-
Upgrade
Buyback Yield / Dilution
-1121.34%-499.67%-4.07%-9.45%-22.64%-1.96%
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q